Cargando…
Caenorhabditis elegans as a valuable model for the study of anthelmintic pharmacodynamics and drug-drug interactions: The case of ivermectin and eprinomectin
Caenorhabditis elegans is a free-living nematode that has been validated for anthelmintic drug screening. However, this model has not been used to address anthelmintic dose-response-time and drug-drug interactions through matrix array methodology. Eprinomectin (EPM) and Ivermectin (IVM) are macrocyc...
Autores principales: | Suárez, Gonzalo, Alcántara, Ignacio, Salinas, Gustavo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627147/ https://www.ncbi.nlm.nih.gov/pubmed/36339613 http://dx.doi.org/10.3389/fphar.2022.984905 |
Ejemplares similares
-
A Large Impact of Obesity on the Disposition of Ivermectin, Moxidectin and Eprinomectin in a Canine Model: Relevance for COVID-19 Patients
por: Bousquet-Mélou, Alain, et al.
Publicado: (2021) -
Caenorhabditis elegans Infrared-Based Motility Assay Identified New Hits for Nematicide Drug Development
por: Risi, Gastón, et al.
Publicado: (2019) -
Mapping resistance-associated anthelmintic interactions in the model nematode Caenorhabditis elegans
por: Rehborg, Elena G., et al.
Publicado: (2023) -
Mapping resistance-associated anthelmintic interactions in the model nematode Caenorhabditis elegans
por: Rehborg, Elena G., et al.
Publicado: (2023) -
Susceptibility of Angiostrongylus cantonensis Larvae to Anthelmintic Drugs
por: Roquini, Daniel B., et al.
Publicado: (2022)